Position in TMO
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$21,684,829
-$6,007,665 QoQ
Shares Held
44,117
-7.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026OP Asset Management Ltd holds $79,493,622 across 19 Diagnostics & Research names. TMO ranks #1 (27.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
44,117 | $21,684,829 | |
| 2 | DHR |
Danaher Corp /De/
|
65,687 | $12,454,255 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
20,869 | $11,726,082 | |
| 4 | A |
Agilent Technologies, Inc.
|
52,325 | $5,964,003 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
30,227 | $5,154,912 | |
| 6 | NTRA |
Natera, Inc.
|
16,195 | $3,238,838 | |
| 7 | WAT |
Waters Corp /De/
|
10,053 | $2,993,783 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
2,133 | $2,690,139 |
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,684,829 | 44,117 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $27,692,494 | 47,791 | Shares | Sole | 2026-04-21 | |
| 2025-09-30 | $20,171,496 | 41,589 | Shares | Sole | 2026-04-20 | |
| 2025-06-30 | $16,622,238 | 40,996 | Shares | Sole | 2026-04-20 | |
| 2025-03-31 | $21,490,348 | 43,188 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||